A/Prof Heather Thorne
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
88 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classification
DOI: 10.1016/j.ebiom.2026.1061992026
Journal article
Parity and lactation induce T-cell-mediated breast cancer protection
DOI: 10.1038/s41586-025-09713-52023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
2015
Journal article
Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort
DOI: 10.1111/bju.127922012
Journal article
High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer
DOI: 10.1111/j.1464-410X.2012.11519.x2011
Journal article
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families
DOI: 10.1158/1940-6207.CAPR-10-03972008
Journal article
Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation
DOI: 10.1158/1078-0432.CCR-07-5237
RECENT SCHOLARLY WORKS
2024
Journal article
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset
DOI: 10.1016/j.ajhg.2024.07.0042024
Journal article
Research autopsy programmes in oncology: shared experience from 14 centres across the world
DOI: 10.1002/path.62712023
Journal article
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
DOI: 10.1002/cam4.62722023
Journal article
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme
DOI: 10.1111/his.149062023
Journal article
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
DOI: 10.1016/j.ejca.2023.02.0222023
Journal article
The impact of coding germline variants on contralateral breast cancer risk and survival
DOI: 10.1016/j.ajhg.2023.02.0032023
Journal article
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
DOI: 10.1038/s41588-023-01320-22023
Journal article
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
DOI: 10.1038/s41431-022-01257-w